Test Price
2,800 AED✅ Home Collection Available
IBA57 Gene (Multiple Mitochondrial Dysfunctions Syndrome Type 3) Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity for IBA57-related Multiple Mitochondrial Dysfunctions Syndrome Type 3 via ISO 9001:2015‑certified NGS technology. Includes hospital‑grade home collection, temperature‑controlled cold‑chain logistics, and post‑test clinical guidance across Dubai, Abu Dhabi, and all Emirates.
💰 Price: 2,800 AED | 📞 WhatsApp for Insurance & Direct Billing: +971 54 548 8731
🧪 TAT: 3–4 Weeks | 🏠 Home Collection: 8 AM – 11 PM (Premium Cold Chain) | 📋 DHA Facility License: 1143
Test Overview & Methodology
The IBA57 NGS test sequences the entire coding region and splice sites of the IBA57 gene to detect pathogenic variants responsible for Multiple Mitochondrial Dysfunctions Syndrome Type 3 (MMDS3), a severe neurometabolic disorder. This definitive genetic diagnosis enables targeted clinical management, family planning, and anticipatory care for patients in the UAE.
| Feature | Our IBA57 NGS Test | Closest Alternative (Limited Panel / Sanger) |
|---|---|---|
| Precision | 99.9% Diagnostic Sensitivity (full gene coverage + intronic boundaries) | ~95% Sensitivity (partial coverage, exons only) |
| Methodology | NGS (Next Generation Sequencing) – ISO 9001:2015 Facility | Classical Sanger sequencing or limited NGS panel without full IBA57 coverage |
| Turnaround Speed | 3–4 Weeks (Fast Track Available) | 6–8 Weeks |
| Expert Alignment | Reviewed by DHA-licensed Consultant Medical Geneticist | May lack disease‑specific specialist interpretation |
Physician Insight & Safety Protocols
“As a Consultant Medical Geneticist, I recognize the profound impact that a confirmed diagnosis of Multiple Mitochondrial Dysfunctions Syndrome Type 3 can have on families. This comprehensive NGS analysis of the IBA57 gene offers the highest molecular resolution available in the UAE. However, the genetic result must always be interpreted alongside the patient’s full clinical presentation, family history, and metabolic profile.”
Advisory Notice
⚠️ Clinical Warning
Do not discontinue, alter, or initiate any medication (including antiepileptics, mitochondrial supplement cocktails, or vitamins) without direct consultation with your treating physician. Test results alone should not guide therapeutic changes.
Exclusion Criteria & Emergency Red Flags
- Active metabolic crisis (e.g., severe acidosis, refractory seizures, or respiratory compromise) – seek emergency care immediately; genetic testing should be deferred.
- Inability to provide a peripheral blood sample or contraindication to venipuncture.
- Known acute infection that may compromise sample integrity – consult our medical team for clearance.
- If you or your child experience sudden neurological deterioration, loss of consciousness, or severe respiratory distress, do not wait for test results—go to the nearest Emergency Department.
Patient FAQ & Clinical Guidance
1. What does the IBA57 NGS test detect, and who should order it?
Answer: This test identifies pathogenic mutations in the IBA57 gene responsible for Multiple Mitochondrial Dysfunctions Syndrome Type 3 (MMDS3). It is indicated for patients presenting with hypotonia, developmental delay, lactic acidosis, and other features suggestive of a mitochondrial disorder, especially when previous metabolic or genetic workup has been inconclusive.
2. How long do results take, and can I use the test for insurance claims?
Answer: The turnaround time is 3–4 weeks from receipt of a high-quality peripheral blood sample. We assist with direct billing and insurance pre‑approval; contact us via WhatsApp at +971 54 548 8731 for a pre‑approval request.
3. Is home sample collection available, and is it safe for children and adults?
Answer: Yes. Our DHA‑licensed phlebotomists perform VIP mobile phlebotomy with temperature‑controlled cold‑chain logistics from 8 AM to 11 PM, seven days a week. The service is suitable for all ages, including neonates and children, and follows strict infection‑control protocols.
UAE Regulatory & Data Privacy Adherence
Data Protection & Health Information Security
This test is conducted in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – ensuring secure handling of digital health records and test results.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – covering clinical safety, informed consent, and patient rights for diagnostic procedures.
All samples are processed in our ISO 9001:2015 certified laboratory (Certificate: INT/EGQ/2509DA/3139) under strict quality management protocols.
Clinical & Logistical Metadata
| Test Name | IBA57 Gene (Multiple Mitochondrial Dysfunctions Syndrome Type 3) Genetic Test – NGS |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks (Fast Track Available) |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) – 3–5 mL |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene & splice site analysis |
| ICD-10-CM Code | G71.3, E88.49, Z13.79 |
| LOINC Code | 101847-9 |
| DHA Facility License & Laboratory Address | License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians